A cancer vacine containing four HLA-A*2402-restricted peptide epitopes with potential immunostimulatory and antitumor activities. Peptide epitopes in this … [Read more...]
Search Results for: multi
stage I multiple myeloma
Relatively few cancer cells have spread throughout the body. There may be no symptoms of disease. … [Read more...]
bcr-abl p210-b3a2 breakpoint-derived multipeptide vaccine
A multipeptide vaccine consisting of five peptides derived from the bcr-abl p210-b3a2 breakpoint fusion protein with potential antineoplastic activity. … [Read more...]
multikinase inhibitor AT9283
A small-molecule inhibitor of several kinases with potential antineoplastic activity. Multikinase inhibitor AT9283 binds to and inhibits Aurora kinases A and … [Read more...]
hTERT I540 / R572Y / D988Y multipeptide vaccine
A peptide vaccine consisting of multiple epitopes derived from the human telomerase reverse transcriptase (hTERT), the catalytic subunit of human telomerase, … [Read more...]
MultiHance
(Other name for: gadobenate dimeglumine) … [Read more...]
LY6K / VEGFR1 / VEGFR2 multipeptide vaccine
A multipeptide vaccine consisting of peptides derived from lymphocyte antigen 6 complex locus K (LY6K) and type I and II vascular endothelial growth factor … [Read more...]
HLA-A*2402-restricted URLC10-CDCA1-VEGFR1-VEGFR2 multipeptide vaccine
A cancer vaccine containing four HLA-A*2402-restricted peptide epitopes with potential immunostimulatory and antitumor activities. The peptide epitopes are … [Read more...]
multitargeted receptor tyrosine kinase inhibitor MP470
An orally bioavailable synthetic carbothioamide with potential antineoplastic activity. Multitargeted receptor tyrosine kinase inhibitor MP470 binds to mutant … [Read more...]
HLA-A*0201-restricted VEGFR1-VEGFR2 multipeptide vaccine
A cancer vaccine containing two HLA-A*0201-restricted peptide epitopes with potential immunostimulatory and antitumor activities. Peptide epitopes in this … [Read more...]